Are Alterations in DNA Methylation Related to CKD Development?

The modifications in genomic DNA methylation are involved in the regulation of normal and pathological cellular processes. The epigenetic regulation stimulates biological plasticity as an adaptive response to variations in environmental factors. The role of epigenetic changes is vital for the develo...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2022-06, Vol.23 (13), p.7108
Main Authors: Rysz, Jacek, Franczyk, Beata, Rysz-Górzyńska, Magdalena, Gluba-Brzózka, Anna
Format: Article
Language:English
Subjects:
Atherogenesis
Binding sites
Biomarkers
Cardiovascular disease
chronic kidney disease
Cytokines
Deoxyribonucleic acid
Diabetes
DNA
DNA Methylation
Epigenesis, Genetic
Epigenetics
Fibrosis
Gene expression
Genes
Genomes
Glomerular Filtration Rate
Homocysteine
Humans
Hypertension
Hypoxia
Inflammation
Kidney - metabolism
Kidney diseases
MicroRNAs
Plastic foam
Proteins
Renal function
Renal Insufficiency, Chronic - metabolism
Review
Transcription factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713
cites cdi_FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713
container_end_page
container_issue 13
container_start_page 7108
container_title International journal of molecular sciences
container_volume 23
creator Rysz, Jacek
Franczyk, Beata
Rysz-Górzyńska, Magdalena
Gluba-Brzózka, Anna
description The modifications in genomic DNA methylation are involved in the regulation of normal and pathological cellular processes. The epigenetic regulation stimulates biological plasticity as an adaptive response to variations in environmental factors. The role of epigenetic changes is vital for the development of some diseases, including atherogenesis, cancers, and chronic kidney disease (CKD). The results of studies presented in this review have suggested that altered DNA methylation can modulate the expression of pro-inflammatory and pro-fibrotic genes, as well those essential for kidney development and function, thus stimulating renal disease progression. Abnormally increased homocysteine, hypoxia, and inflammation have been suggested to alter epigenetic regulation of gene expression in CKD. Studies of renal samples have demonstrated the relationship between variations in DNA methylation and fibrosis and variations in estimated glomerular filtration rate (eGFR) in human CKD. The unravelling of the genetic-epigenetic profile would enhance our understanding of processes underlying the development of CKD. The understanding of multifaceted relationship between DNA methylation, genes expression, and disease development and progression could improve the ability to identify individuals at risk of CKD and enable the choice of appropriate disease management.
doi_str_mv 10.3390/ijms23137108
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ef6bee413ed24e28a7dd97f8739b8add</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ef6bee413ed24e28a7dd97f8739b8add</doaj_id><sourcerecordid>2687720631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713</originalsourceid><addsrcrecordid>eNpdkU1P3DAQhi1EBZRy41xF6qWHbrE9jj8uVKtdoKjQShWcLTueQFZJvLWzSPz7ZllACyePxo8ezcxLyDGj3wEMPWkWXebAQDGqd8gBE5xPKJVqd6veJx9zXlDKgZdmj-xDqalkDA7I6TRhMW0HTG5oYp-Lpi_mv6fFNQ73j-1Tr_iLY4GhGGIx-zUv5viAbVx22A8_PpEPtWszHj2_h-T2_Oxm9nNy9eficja9mlSC6mEiqPOGg0ctjBHO1Bi8AC5RelGVzlUKvJIqQK2lB2HKmvtSs9KUXgFTDA7J5cYbolvYZWo6lx5tdI19asR0Z10amqpFi7X0iIIBBi6Qa6dCMKrWCozXLoTRdbpxLVe-w1CNeyTXvpG-_embe3sXH6zhUlGhR8HXZ0GK_1aYB9s1ucK2dT3GVbZcaqU4lbCe-8s7dBFXqR9PtabGCDgVa-rbhqpSzDlh_ToMo3Ydst0OecQ_by_wCr-kCv8BALOhMQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2686112041</pqid></control><display><type>article</type><title>Are Alterations in DNA Methylation Related to CKD Development?</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Rysz, Jacek ; Franczyk, Beata ; Rysz-Górzyńska, Magdalena ; Gluba-Brzózka, Anna</creator><creatorcontrib>Rysz, Jacek ; Franczyk, Beata ; Rysz-Górzyńska, Magdalena ; Gluba-Brzózka, Anna</creatorcontrib><description>The modifications in genomic DNA methylation are involved in the regulation of normal and pathological cellular processes. The epigenetic regulation stimulates biological plasticity as an adaptive response to variations in environmental factors. The role of epigenetic changes is vital for the development of some diseases, including atherogenesis, cancers, and chronic kidney disease (CKD). The results of studies presented in this review have suggested that altered DNA methylation can modulate the expression of pro-inflammatory and pro-fibrotic genes, as well those essential for kidney development and function, thus stimulating renal disease progression. Abnormally increased homocysteine, hypoxia, and inflammation have been suggested to alter epigenetic regulation of gene expression in CKD. Studies of renal samples have demonstrated the relationship between variations in DNA methylation and fibrosis and variations in estimated glomerular filtration rate (eGFR) in human CKD. The unravelling of the genetic-epigenetic profile would enhance our understanding of processes underlying the development of CKD. The understanding of multifaceted relationship between DNA methylation, genes expression, and disease development and progression could improve the ability to identify individuals at risk of CKD and enable the choice of appropriate disease management.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23137108</identifier><identifier>PMID: 35806113</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Atherogenesis ; Binding sites ; Biomarkers ; Cardiovascular disease ; chronic kidney disease ; Cytokines ; Deoxyribonucleic acid ; Diabetes ; DNA ; DNA Methylation ; Epigenesis, Genetic ; Epigenetics ; Fibrosis ; Gene expression ; Genes ; Genomes ; Glomerular Filtration Rate ; Homocysteine ; Humans ; Hypertension ; Hypoxia ; Inflammation ; Kidney - metabolism ; Kidney diseases ; MicroRNAs ; Plastic foam ; Proteins ; Renal function ; Renal Insufficiency, Chronic - metabolism ; Review ; Transcription factors</subject><ispartof>International journal of molecular sciences, 2022-06, Vol.23 (13), p.7108</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713</citedby><cites>FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2686112041/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2686112041?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35806113$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rysz, Jacek</creatorcontrib><creatorcontrib>Franczyk, Beata</creatorcontrib><creatorcontrib>Rysz-Górzyńska, Magdalena</creatorcontrib><creatorcontrib>Gluba-Brzózka, Anna</creatorcontrib><title>Are Alterations in DNA Methylation Related to CKD Development?</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>The modifications in genomic DNA methylation are involved in the regulation of normal and pathological cellular processes. The epigenetic regulation stimulates biological plasticity as an adaptive response to variations in environmental factors. The role of epigenetic changes is vital for the development of some diseases, including atherogenesis, cancers, and chronic kidney disease (CKD). The results of studies presented in this review have suggested that altered DNA methylation can modulate the expression of pro-inflammatory and pro-fibrotic genes, as well those essential for kidney development and function, thus stimulating renal disease progression. Abnormally increased homocysteine, hypoxia, and inflammation have been suggested to alter epigenetic regulation of gene expression in CKD. Studies of renal samples have demonstrated the relationship between variations in DNA methylation and fibrosis and variations in estimated glomerular filtration rate (eGFR) in human CKD. The unravelling of the genetic-epigenetic profile would enhance our understanding of processes underlying the development of CKD. The understanding of multifaceted relationship between DNA methylation, genes expression, and disease development and progression could improve the ability to identify individuals at risk of CKD and enable the choice of appropriate disease management.</description><subject>Atherogenesis</subject><subject>Binding sites</subject><subject>Biomarkers</subject><subject>Cardiovascular disease</subject><subject>chronic kidney disease</subject><subject>Cytokines</subject><subject>Deoxyribonucleic acid</subject><subject>Diabetes</subject><subject>DNA</subject><subject>DNA Methylation</subject><subject>Epigenesis, Genetic</subject><subject>Epigenetics</subject><subject>Fibrosis</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Genomes</subject><subject>Glomerular Filtration Rate</subject><subject>Homocysteine</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypoxia</subject><subject>Inflammation</subject><subject>Kidney - metabolism</subject><subject>Kidney diseases</subject><subject>MicroRNAs</subject><subject>Plastic foam</subject><subject>Proteins</subject><subject>Renal function</subject><subject>Renal Insufficiency, Chronic - metabolism</subject><subject>Review</subject><subject>Transcription factors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1P3DAQhi1EBZRy41xF6qWHbrE9jj8uVKtdoKjQShWcLTueQFZJvLWzSPz7ZllACyePxo8ezcxLyDGj3wEMPWkWXebAQDGqd8gBE5xPKJVqd6veJx9zXlDKgZdmj-xDqalkDA7I6TRhMW0HTG5oYp-Lpi_mv6fFNQ73j-1Tr_iLY4GhGGIx-zUv5viAbVx22A8_PpEPtWszHj2_h-T2_Oxm9nNy9eficja9mlSC6mEiqPOGg0ctjBHO1Bi8AC5RelGVzlUKvJIqQK2lB2HKmvtSs9KUXgFTDA7J5cYbolvYZWo6lx5tdI19asR0Z10amqpFi7X0iIIBBi6Qa6dCMKrWCozXLoTRdbpxLVe-w1CNeyTXvpG-_embe3sXH6zhUlGhR8HXZ0GK_1aYB9s1ucK2dT3GVbZcaqU4lbCe-8s7dBFXqR9PtabGCDgVa-rbhqpSzDlh_ToMo3Ydst0OecQ_by_wCr-kCv8BALOhMQ</recordid><startdate>20220626</startdate><enddate>20220626</enddate><creator>Rysz, Jacek</creator><creator>Franczyk, Beata</creator><creator>Rysz-Górzyńska, Magdalena</creator><creator>Gluba-Brzózka, Anna</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220626</creationdate><title>Are Alterations in DNA Methylation Related to CKD Development?</title><author>Rysz, Jacek ; Franczyk, Beata ; Rysz-Górzyńska, Magdalena ; Gluba-Brzózka, Anna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Atherogenesis</topic><topic>Binding sites</topic><topic>Biomarkers</topic><topic>Cardiovascular disease</topic><topic>chronic kidney disease</topic><topic>Cytokines</topic><topic>Deoxyribonucleic acid</topic><topic>Diabetes</topic><topic>DNA</topic><topic>DNA Methylation</topic><topic>Epigenesis, Genetic</topic><topic>Epigenetics</topic><topic>Fibrosis</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Genomes</topic><topic>Glomerular Filtration Rate</topic><topic>Homocysteine</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypoxia</topic><topic>Inflammation</topic><topic>Kidney - metabolism</topic><topic>Kidney diseases</topic><topic>MicroRNAs</topic><topic>Plastic foam</topic><topic>Proteins</topic><topic>Renal function</topic><topic>Renal Insufficiency, Chronic - metabolism</topic><topic>Review</topic><topic>Transcription factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rysz, Jacek</creatorcontrib><creatorcontrib>Franczyk, Beata</creatorcontrib><creatorcontrib>Rysz-Górzyńska, Magdalena</creatorcontrib><creatorcontrib>Gluba-Brzózka, Anna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Health &amp; Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rysz, Jacek</au><au>Franczyk, Beata</au><au>Rysz-Górzyńska, Magdalena</au><au>Gluba-Brzózka, Anna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are Alterations in DNA Methylation Related to CKD Development?</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-06-26</date><risdate>2022</risdate><volume>23</volume><issue>13</issue><spage>7108</spage><pages>7108-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>The modifications in genomic DNA methylation are involved in the regulation of normal and pathological cellular processes. The epigenetic regulation stimulates biological plasticity as an adaptive response to variations in environmental factors. The role of epigenetic changes is vital for the development of some diseases, including atherogenesis, cancers, and chronic kidney disease (CKD). The results of studies presented in this review have suggested that altered DNA methylation can modulate the expression of pro-inflammatory and pro-fibrotic genes, as well those essential for kidney development and function, thus stimulating renal disease progression. Abnormally increased homocysteine, hypoxia, and inflammation have been suggested to alter epigenetic regulation of gene expression in CKD. Studies of renal samples have demonstrated the relationship between variations in DNA methylation and fibrosis and variations in estimated glomerular filtration rate (eGFR) in human CKD. The unravelling of the genetic-epigenetic profile would enhance our understanding of processes underlying the development of CKD. The understanding of multifaceted relationship between DNA methylation, genes expression, and disease development and progression could improve the ability to identify individuals at risk of CKD and enable the choice of appropriate disease management.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35806113</pmid><doi>10.3390/ijms23137108</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-06, Vol.23 (13), p.7108
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ef6bee413ed24e28a7dd97f8739b8add
source Open Access: PubMed Central; Publicly Available Content (ProQuest)
subjects Atherogenesis
Binding sites
Biomarkers
Cardiovascular disease
chronic kidney disease
Cytokines
Deoxyribonucleic acid
Diabetes
DNA
DNA Methylation
Epigenesis, Genetic
Epigenetics
Fibrosis
Gene expression
Genes
Genomes
Glomerular Filtration Rate
Homocysteine
Humans
Hypertension
Hypoxia
Inflammation
Kidney - metabolism
Kidney diseases
MicroRNAs
Plastic foam
Proteins
Renal function
Renal Insufficiency, Chronic - metabolism
Review
Transcription factors
title Are Alterations in DNA Methylation Related to CKD Development?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T05%3A31%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20Alterations%20in%20DNA%20Methylation%20Related%20to%20CKD%20Development?&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Rysz,%20Jacek&rft.date=2022-06-26&rft.volume=23&rft.issue=13&rft.spage=7108&rft.pages=7108-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23137108&rft_dat=%3Cproquest_doaj_%3E2687720631%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-40ab923be84994a9fedb4326e6b4c5aac73b767d3f86b3495f2b581595b731713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2686112041&rft_id=info:pmid/35806113&rfr_iscdi=true